Text Message Reminders for Pediatric COVID-19 and Flu Vaccines

Recruiting at 3 trial locations

Overseen By Alex Fiks, MD MSCE

Age: < 18

Sex: Any

Trial Phase: Academic

Sponsor: Columbia University

Disqualifiers: Opted out of text messages, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

50000 Participants Needed

Trial Summary

What is the purpose of this trial?

This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.

Research Team

Melissa Stockwell, MD MPH

Principal Investigator

Columbia University

Alex Fiks, MD

Principal Investigator

Children's Hospital of Philadelphia

Eligibility Criteria

This trial is for parents or guardians of children eligible to receive COVID-19 and influenza vaccines. It's focused on those who are part of the AAP PROS network practices, aiming to see if text reminders can improve vaccination rates.

Inclusion Criteria

Language listed in electronic health record is English or Spanish

Child receives care at study site

My child is between 6 months and 17 years old and needs COVID-19 and flu shots.

Exclusion Criteria

I have chosen not to receive text messages from the clinic.

Language listed in electronic health record is not English or Spanish

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Parents of eligible children receive text message reminders for COVID-19 and/or influenza vaccines

7 months

Follow-up

Participants are monitored for vaccine receipt and timeliness

7 months

Treatment Details

Interventions

• Text Message Reminders

Trial Overview The study tests whether sending text message reminders can increase the number of kids getting their flu and COVID-19 shots. Different groups will get reminders for just one vaccine or both, to compare effectiveness.

Participant Groups

Group I: Text message influenza vaccine reminders Experimental Treatment 1 Intervention

Text message reminders only for influenza vaccination

Group II: Text message influenza and COVID-19 vaccine reminders Experimental Treatment 1 Intervention

Text message reminders for both influenza and COVID-19 vaccinations

Group III: Text message COVID-19 vaccine reminders Experimental Treatment 1 Intervention

Text message reminders only for COVID-19 vaccination

Group IV: Usual Care Active Control 1 Intervention

Usual care has no text message

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials

1,529

Recruited

2,832,000+

University of Pennsylvania

Collaborator

Trials

2,118

Recruited

45,270,000+

American Academy of Pediatrics

Collaborator

Trials

46

Recruited

4,071,000+

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator

Trials

3,361

Recruited

5,516,000+

Children's Hospital of Philadelphia

Collaborator

Trials

749

Recruited

11,400,000+